Recruiting Tardive Dyskinesia Studies in Bryant
About Tardive Dyskinesia Clinical Trials in Bryant
Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive movements, especially of the face and tongue, caused by long-term use of certain psychiatric medications. It can be socially disabling and persistent. Treatment includes VMAT2 inhibitors (valbenazine, deutetrabenazine).
There are currently 1 tardive dyskinesia clinical trials recruiting participants in Bryant, AR. These studies are seeking a combined 50 participants. Research is being sponsored by Neurocrine Biosciences. Clinical trial participation is free and participants receive study-related medical care at no cost.
Tardive Dyskinesia Clinical Trials in Bryant — FAQ
Are there tardive dyskinesia clinical trials in Bryant?
Yes, there are 1 tardive dyskinesia clinical trials currently recruiting in Bryant, AR. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Bryant?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bryant research site will contact you about next steps.
Are clinical trials in Bryant free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bryant studies also compensate for your time and travel.
What tardive dyskinesia treatments are being tested?
The 1 active trials in Bryant are testing new therapies including novel drugs, biologics, and treatment approaches for tardive dyskinesia.
Data updated March 2, 2026 from ClinicalTrials.gov